In creating the Emory Molecular and Translational Imaging Center (EMTIC), we have built upon a uniquely supportive Atlanta biomedical environment, a flourishing imaging research community across Emory University and the Georgia Institute of Technology (Georgia Tech), and remarkable growth of the Winship Cancer Institute. The vision and mission for EMTIC is a cross-disciplinary scientific, administrative, and educational network that encompasses imaging scientists and basic and clinician scientists working in areas vital to cancer diagnosis and therapeutics. As conceived, EMTIC is the multi-faceted connector that joins disciplines to accelerate innovative methodological developments and foster their rapid clinical translation. Vital to this mission, EMTIC is closely .aligned with strategic and transforming investments in imaging technology, biomarker development, predictive and personalized medicine, and nanotechnology based at Emory and Georgia Tech. Progress in the development and validation of molecular imaging cancer biomarkers will be founded in a structure of three major Research Projects, four Specialized Resources (Cores), investment in Developmental Funds to support Pilot projects, and a focused Career Development Component. The Research Projects include (Project #1) a translational study of prostate cancer patients using [[18]F]FACBC, an amino acid transporter ligand developed at Emory and an example of the bench-to-bedside capabilities of our investigative team. Project #2 will develop and validate selective chemokine PET markers in head and neck cancer. In Project #3 we will evaluate a unique target-specific molecular MRI probe in a breast cancer animal model. Project #4 tests a novel near-infrared (NIR) fluorescent dye in prostate cancer. Specialized Resources for Imaging (Core A), Tracer Development (Core B), Biostatistics, Modeling, and Data Management (Core C), and Animals, Pathology, and Tumor Models (Core D) will provide support for the Research Projects as well as Year 1 and future Pilot Projects. EMTIC will also provide an ideal structure for support of an integrated Career Development Program to equip the future imaging scientist with the interdisciplinary technical and translational skills to specialize in cellular and molecular imaging for cancer care.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRRB-9 (J1))
Program Officer
Menkens, Anne E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
Schools of Medicine
United States
Zip Code
Orza, Anamaria; Yang, Yi; Feng, Ting et al. (2016) A nanocomposite of Au-AgI core/shell dimer as a dual-modality contrast agent for x-ray computed tomography and photoacoustic imaging. Med Phys 43:589
Tian, Zhiqiang; Liu, Lizhi; Zhang, Zhenfeng et al. (2016) Superpixel-Based Segmentation for 3D Prostate MR Images. IEEE Trans Med Imaging 35:791-801
Dance, David R; Sechopoulos, Ioannis (2016) Dosimetry in x-ray-based breast imaging. Phys Med Biol 61:R271-R304
Schuster, David M; Nanni, Cristina; Fanti, Stefano (2016) PET Tracers Beyond FDG in Prostate Cancer. Semin Nucl Med 46:507-521
Odewole, Oluwaseun A; Oyenuga, Oyeladun A; Tade, Funmilayo et al. (2015) Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis. Mol Imaging Biol 17:277-83
Lu, Guolan; Wang, Dongsheng; Qin, Xulei et al. (2015) Framework for hyperspectral image processing and quantification for cancer detection during animal tumor surgery. J Biomed Opt 20:126012
Pike, Robert; Sechopoulos, Ioannis; Fei, Baowei (2015) A minimum spanning forest based classification method for dedicated breast CT images. Med Phys 42:6190-202
Qin, Xulei; Fei, Baowei (2015) DTI template-based estimation of cardiac fiber orientations from 3D ultrasound. Med Phys 42:2915-24
Kaluzova, Milota; Bouras, Alexandros; Machaidze, Revaz et al. (2015) Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles. Oncotarget 6:8788-806
Wang, Dongsheng; Fei, Baowei; Halig, Luma V et al. (2014) Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. ACS Nano 8:6620-32

Showing the most recent 10 out of 74 publications